Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
12.82
-0.07 (-0.54%)
Jan 26, 2026, 10:01 AM EST - Market open
Arvinas Market Cap
Arvinas has a market cap or net worth of $823.36 million as of January 26, 2026. Its market cap has decreased by -38.33% in one year.
Market Cap
823.36M
Enterprise Value
49.55M
1-Year Change
-38.33%
Ranking
Category
Stock Price
$12.82
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $823.36M, an increase of 59.52%. That is a compound annual growth rate of 6.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 827.85M | 8.68% |
| Dec 31, 2025 | 761.70M | -42.17% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geron | 880.93M |
| YD Bio | 869.15M |
| Bright Minds Biosciences | 851.32M |
| Omeros | 845.84M |
| Valneva SE | 837.21M |
| enGene Holdings | 815.20M |
| KalVista Pharmaceuticals | 809.75M |
| MapLight Therapeutics | 784.67M |